Skip to main content
. Author manuscript; available in PMC: 2022 Aug 31.
Published in final edited form as: J Neurosci Res. 2020 Aug 27;98(11):2349–2356. doi: 10.1002/jnr.24710

Fig. 3.

Fig. 3.

A. Bright field tiled and magnified images (left) [dashed line box shows magnified region on the right] of GAT-3 immunostaining of striatum (Str) and GPe in WT vs. R6/2 mice showed no change in Str GAT-3 expression levels, but a significant decrease in GAT-3 expression in the GPe. Bar graphs (right) show quantitative data. B. Synaptoneurosome preparations of Str or GPe from WT vs. R6/2 mice showed no change in GAT-3 expression in the Str, but a statistically significant decrease of GAT-3 expression in the GPe.